Life Biosciences
Boston, US · Founded 2017 · Delaware LLC · 4 known investors
Find your way into Life Biosciences
1,414 people in our graph share verified history with the Life Biosciences team — schools, employers, funds. One of them is your warm intro.
Dominic Jacquessonunlockedknows Amit Shashank · together at University of Oxford (overlapped)
knows the team · via Genocea Biosciences
×2knows the team · via GlaxoSmithKline
×2knows the team · via University of Michigan
knows the team · via Massachusetts Institute of Technology
knows the team · via Harvard Medical School
Longevity company with diversified therapies to extend healthy human lifespan
Founders & leadership
Life Biosciences was founded in 2017 by David Sinclair.
DS
David SinclairinFounder · Board Member, Investor, AdvisorA Harvard Medical School professor of genetics with a Ph.D. from UNSW and postdoctoral training at MIT, Sinclair has published over 200 papers on aging biology and holds more than 50 patents; he is director of Life Biosciences, a longevity company developing therapies to extend healthy human lifespan.
GM
Gerald McLaughlinExecutive
SR
Sharon Rosenzweig-LipsoninChief Scientific Officer
MR
Michael RingelinChief Operating OfficerMichael Ringel holds a B.A. in biology from Princeton University, a Ph.D. in biology from Imperial College, and a J.D. from Harvard Law School. He spent over 25 years at BCG as a Managing Director and Senior Partner before joining Life Biosciences as Chief Operating Officer.
AS
Amit ShashankinChief Administrative Officer + General CounselAmit Shashank is an Executive Officer at Life Biosciences, a longevity company developing therapies to extend healthy human lifespan. He brings over two decades of experience in technology and biotech, with prior roles including general counsel at a public company, and expertise in M&A, corporate finance, and venture capital transactions.
AT
Alexander Tristan EdwardsExecutive
MK
Mehmood KhaninExecutiveMehmood Khan previously held senior leadership positions including Chief Scientific Officer of Global R&D at PepsiCo and President of Global R&D at Takeda Pharmaceuticals, with earlier clinical expertise as Director of the Diabetes, Endocrine and Nutritional Trials Unit at Mayo Clinic and a fellowship in clinical endocrinology and nutrition from the University of Minnesota. He is now Chief Executive Officer of Life Biosciences, a longevity company developing therapies to extend healthy human lifespan.
BM
Brian MaloneExecutive
Board
IS
Ilan SternBoard director
SG
Stuart GibsonBoard director
DG
David GuyerBoard director
BD
Bracken DarrellBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$154.4M disclosed across 3 of 4 rounds · 2018–2025
▶$31MraisedApr 2026 · 8 investors · OtherRule 506(b)
▶$31MraisedApr 2026 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Stuart GibsonDirector
- Gerald McLaughlinExecutive Officer, Director
- David GuyerDirector
- David SinclairDirector
- Sharon Rosenzweig-LipsonExecutive Officer
- Michael RingelExecutive Officer
- Amit ShashankExecutive Officer
- Ilan SternDirector
- Offering amount
- $31M
- Amount sold
- $31M
- Finders' fees
- $30K
- Placement agents
- Chatsworth Securities LLC
- First sale
- Nov 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$74.8MraisedJun 2021 · 35 investors · OtherRule 506(b)
▶$74.8MraisedJun 2021 · 35 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ilan SternDirector
- Bracken DarrellDirector
- Mehmood KhanExecutive Officer, Director
- Alexander Tristan EdwardsPromoter
- Brian MaloneExecutive Officer
- David SinclairDirector, Promoter
- Stuart GibsonDirector
- Amit ShashankExecutive Officer
- Offering amount
- $100M
- Amount sold
- $74.8M
- Finders' fees
- $321.7K
- Placement agents
- McKenny McFarlane Capital Ltd, Morgan Stanley Australia Securities Limited
- First sale
- May 2020
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶Undisclosed amountofferedSep 2020 · 6 investors · OtherRule 506(b)
▶Undisclosed amountofferedSep 2020 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Bracken DarrellDirector
- David SinclairDirector
- Ilan SternDirector
- Stuart GibsonDirector
- Alexander Tristan EdwardsExecutive Officer
- Mehmood KhanExecutive Officer
- Amit ShashankExecutive Officer
- Brian MaloneExecutive Officer
- First sale
- Sep 2020
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$48.6MraisedJan 2019 · 45 investors · OtherRule 506(c)
▶$48.6MraisedJan 2019 · 45 investors · Other
Rule 506(c)Officers, directors & promoters on the filing
- Bracken DarrellDirector
- Adam NeumannDirector
- David SinclairDirector, Promoter
- Alexander Tristan EdwardsExecutive Officer, Promoter
- Brian MaloneExecutive Officer
- Stuart GibsonDirector
- Offering amount
- $50.9M
- Amount sold
- $48.6M
- Finders' fees
- $1.5M
- Placement agents
- Morgan Stanley Australia Securities Limited, Race Rock Capital LLC
- First sale
- Aug 2018
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Precision BioSciences78 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Pano AI64 shared keywordsPano develops artificial intelligence and machine learning technology solutions to help utility companies and fire agencies detect and manage wildfire threats. The company serves emergency managers and professionals in the utility and fire industries seeking to protect communities from wildfires.
Companies competing with Life Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Fierce Biotech Fundraising Tracker '26: InduPro assembles $77M; Vaderis nets $152M series Bfiercebiotech.com · Aug 2026Frequently asked questions
- What does Life Biosciences do?
- Longevity company with diversified therapies to extend healthy human lifespan
- Who founded Life Biosciences?
- Life Biosciences was founded by David Sinclair in 2017.
- Who are Life Biosciences's investors?
- Life Biosciences's investors include Alpha Wave Global, The Venture Collective, W ventures, Life Biosciences.
- How much funding has Life Biosciences raised?
- Life Biosciences has disclosed $154.4M raised across 3 of its 4 known rounds.
- Where is Life Biosciences headquartered?
- Life Biosciences is headquartered in Boston, US.